logo-loader

Clinigen boss happy with contribution from all divisions in latest half year

Published: 10:26 16 Mar 2017 GMT

Shaun Chilton, chief executive at Clinigen Group PLC (LON:CLIN), told Proactive he was very happy with the firm's latest half year.
The specialty pharma group confirmed that underlying profits [adjusted EBITDA] rose 34% to £30mln in the half year to end December on revenues of £131mln (£156mln)
"I think it's a strong performance and particularly because every single business division contributed," he told Andrew Scott.

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

33 minutes ago